Driada Medical Primos

Methenolone Enanthate 100 mg/mL (Driada Medical Primos) is an injectable anabolic-androgenic steroid containing methenolone enanthate (also known as Primobolan Depot) at a concentration of 100 mg per mL, typically supplied in a 10 mL vial by Driada Medical, a Europe-based manufacturer often linked to underground performance-enhancing suppliers. It is a DHT-derived steroid with mild anabolic effects and low androgenic activity, primarily used off-label by bodybuilders and athletes for lean muscle preservation, fat loss, and cutting cycles without significant water retention or estrogenic side effects. Medically, it has been indicated for treating muscle wasting due to chronic illnesses, severe burns, or osteoporosis, though it is rarely prescribed today due to availability and regulatory issues—most use is non-therapeutic and illegal without prescription in many countries, including India.

How It Works

Methenolone enanthate is a long-acting ester of methenolone, a synthetic DHT analog that binds to androgen receptors to promote protein synthesis, nitrogen retention, and collagen production, supporting lean tissue growth and recovery while minimizing fat accumulation. The enanthate ester provides sustained release over 10-14 days after intramuscular injection, resulting in gradual, high-quality gains (e.g., 5-10 lbs of muscle over a cycle) with a favorable anabolic-to-androgenic ratio (about 88:44-57 compared to testosterone’s 100:100). It does not aromatize to estrogen, reducing risks of gynecomastia or bloating, and has low progestogenic activity, making it suitable for drier, more defined physiques.

Dosage and Administration

• Administered via deep intramuscular injection into large muscle groups (e.g., glutes or deltoids) using sterile technique; inject every 7-10 days due to the long half-life (7-10 days).
• Non-medical bodybuilding doses: Men 400-600 mg per week (4-6 mL total), often in 8-12 week cycles; women 50-100 mg per week to avoid virilization. Beginners start at 300-400 mg/week; stack with testosterone (e.g., 200-300 mg/week) for synergy.
• For the 10 mL vial (1,000 mg total): Rotate sites; monitor bloodwork for hormones, lipids, and liver enzymes every 4-6 weeks. Post-cycle therapy (PCT) with SERMs like clomiphene (50 mg/day for 4 weeks) starts 2 weeks after last injection to mitigate suppression.
• Professional administration recommended; do not exceed 800 mg/week to limit risks.

Side Effects

Common side effects include:

• Androgenic: Mild acne, oily skin, accelerated hair loss or body hair growth (in genetically predisposed individuals), and potential voice deepening in women.
• Cardiovascular/Endocrine: Cholesterol imbalances (decreased HDL, increased LDL), mild blood pressure elevation, natural testosterone suppression (leading to low libido or fatigue post-cycle), and injection-site irritation.

Serious risks: Rare but possible liver strain (though injectable form is less hepatotoxic than oral), prostate enlargement, mood changes (e.g., aggression), and virilization in women (clitoral enlargement, menstrual irregularities—often irreversible). Long-term abuse may contribute to cardiovascular disease or infertility; no significant estrogenic effects, but monitor for androgenic overload. Discontinue if severe symptoms like jaundice, chest pain, or swelling occur and seek medical help.

Precautions and Warnings

• Contraindicated in prostate/breast cancer, severe heart/liver/kidney disease, pregnancy, breastfeeding, or hypersensitivity to components (e.g., carrier oil).
• Use caution in those with high cholesterol, hypertension, diabetes (may affect glucose control), or bleeding disorders; not for minors (risk of stunted growth) or women beyond low therapeutic doses.